Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 1 month later Dec 31, 2026 → Jan 31, 2028
See other at-risk trials from Ohio State University Comprehensive Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Dec 31, 2026 to Jan 31, 2028
    • Start date: Sep 1, 2026 to Jan 15, 2027
    • Eligibility criteria expanded, about 10 words
  2. Notable Start date: May 1, 2026 to Sep 1, 2026v4
  3. Notable Recruitment opened
    • Start date: Mar 1, 2026 to May 1, 2026
    • Site details revised
    v3
  4. Notable Start date: Jan 1, 2026 to Mar 1, 2026v2
  5. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This clinical trial compares virtual reality viewing of an unaltered streetscape versus a digitally manipulated opposite streetscape to assess the psychosocial response in participants. Visible measures of neighborhood factors might be associated with health outcomes and risk factors of those outcomes. Short-term exposure to virtual reality environments representing very high or very low levels of neighborhood physical disorder - presence or absence of garbage/litter, presence or absence of graffiti, presence or absence of an abandoned building, presence or absence of large dumpsters, poor or very well-kept building conditions, poor or very well-kept yard conditions, poor or very well-kept road verge conditions may be a safe and effective way to assess psychosocial response in participants.
Trial Details
NCT Number NCT07216534
Lead Sponsor Ohio State University Comprehensive Cancer Center
Conditions
(from sponsor)
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Psychiatric Disorder
Related terms Mental Disorders
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov